Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution

References

• The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf200752759217508116
   PubMed Web of Science ®Google Scholar
• The epidemiology of dry eye disease: report of the epidemiology subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf2007529310717508117
   PubMed Web of Science ®Google Scholar
• BarabinoSMontaldoESolignaniFValenteCMingariMCRolandoMImmune response in the conjunctival epithelium of patients with dry eyeExp Eye Res201091452452920654615
   PubMed Web of Science ®Google Scholar
• MassingaleMLLiXVallabhajosyulaMChenDWeiYAsbellPAAnalysis of inflammatory cytokines in the tears of dry eye patientsCornea20092891023102719724208
   PubMed Web of Science ®Google Scholar
• RolandoMBarabinoSMingariCMorettiSGiuffridaSCalabriaGDistribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyesCornea200524895195416227839
   PubMed Web of Science ®Google Scholar
• TsubotaKFujiharaTSaitoKTakeuchiTConjunctival epithelium expression of HLA-DR in dry eye patientsOphthalmologica1999213116199838252
   PubMed Web of Science ®Google Scholar
• VersuraPProfazioVSchiaviCCamposECHyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro modelsInvest Ophthalmol Vis Sci20115285488549621498621
   PubMed Web of Science ®Google Scholar
• BaudouinCBrignoleFBecquetFPisellaPJGoguelAFlow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammationInvest Ophthalmol Vis Sci1997387145814649191610
   PubMed Web of Science ®Google Scholar
• BaudouinCBrignoleFPisellaPJDe JeanMSGoguelAFlow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin AAdv Exp Med Biol2002506pt B76176912613989
   PubMed Web of Science ®Google Scholar
• BrignoleFDe Saint-JeanMGoldschildMBecquetFGoguelABaudouinCExpression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disordersExp Eye Res19986766876979990333
   PubMed Web of Science ®Google Scholar
• BrignoleFPisellaPJGoldschildMDe Saint JeanMGoguelABaudouinCFlow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyesInvest Ophthalmol Vis Sci20004161356136310798650
   PubMed Web of Science ®Google Scholar
• LopinEDeveneyTAsbellPAImpression cytology: recent advances and applications in dry eye diseaseOcul Surf2009729311019383278
   PubMed Web of Science ®Google Scholar
• MrugaczMZakJBakunowicz-LazarczykAWysockaJMinarowskaAFlow cytometric analysis of HLA-DR antigen in conjunctival epithelial cells of patients with cystic fibrosisEye (Lond)20072181062106616710427
   PubMed Web of Science ®Google Scholar
• PisellaPJBrignoleFDebbaschCFlow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis siccaOphthalmology2000107101841184911013183
   PubMed Web of Science ®Google Scholar
• Research in dry eye: report of the research subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075217919317508121
   PubMed Web of Science ®Google Scholar
• LiangHBrignole-BaudouinFPaulyARianchoLBaudouinCPolyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface studyAdv Ther201128431132521424577
   PubMed Web of Science ®Google Scholar
• Lopez BernalDUbelsJLQuantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservativesCurr Eye Res19911076456561914501
   PubMed Web of Science ®Google Scholar
• MoonSWHwangJHChungSHNamKHThe impact of artificial tears containing hydroxypropyl guar on mucous layerCornea201029121430143520805744
   PubMed Web of Science ®Google Scholar
• SánchezMAArriola-VillalobosPTorralbo-JiménezPThe effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric studyEye (Lond)20102481331133720300126
   PubMed Web of Science ®Google Scholar
• LavappaKSMacyMLShannonJEExamination of ATCC stocks for HeLa marker chromosomes in human cell linesNature197625955402112131250349
   PubMed Web of Science ®Google Scholar
• LavappaKSSurvey of ATCC stocks of human cell lines for HeLa contaminationIn Vitro1978145469475566722
   PubMedGoogle Scholar
• De Saint JeanMBaudouinCDi NolfoMComparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell lineExp Eye Res200478225727414729358
   PubMed Web of Science ®Google Scholar
• JesterJVHo-ChangJModulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contractionExp Eye Res200377558159214550400
   PubMed Web of Science ®Google Scholar
• Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075210815217508118
   PubMed Web of Science ®Google Scholar
• BronAJEvansVESmithJAGrading of corneal and conjunctival staining in the context of other dry eye testsCornea200322764065014508260
   PubMed Web of Science ®Google Scholar
• LempMAReport of the National Eye Institute/Industry workshop on clinical trials in dry eyesCLAO J19952142212328565190
   PubMedGoogle Scholar
• StevensonDTauberJReisBLEfficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study GroupOphthalmology2000107596797410811092
   PubMed Web of Science ®Google Scholar
• AsbellPASpiegelSOphthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician surveyTrans Am Ophthalmol Soc200910720521020126496
   PubMedGoogle Scholar
• PerryHDSolomonRDonnenfeldEDEvaluation of topical cyclosporine for the treatment of dry eye diseaseArch Ophthalmol200812681046105018695097
   PubMedGoogle Scholar
• Cervan-LopezISaenz-Frances-San-BaldomeroFBenitez-Del-CastilloJMGarcia-SanchezJReduction of corneal permeability in patients treated with HP-guar: a fluorophotometric studyArch Soc Esp Oftalmol200681632733216804776
   PubMedGoogle Scholar
• LabbéAPaulyALiangHComparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental studyJ Ocul Pharmacol Ther200622426727816910868
   PubMed Web of Science ®Google Scholar
• SpringsCLNovel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eyeAdv Ther2010271068169020803266
   PubMed Web of Science ®Google Scholar
• SallKNCohenSMChristensenMTSteinJMAn evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eyeEye Contact Lens2006321212616415689
   PubMedGoogle Scholar
• Management and therapy of dry eye disease: report of the management and therapy subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075216317817508120
   PubMed Web of Science ®Google Scholar